NL-OMON35524
Withdrawn
Not Applicable
ovel therapeutic targets and biomarkers in patients with Systemic Lupus Erythematosus - New biomarkers for disease activity and treatment in SLE.
niversitair Medisch Centrum Utrecht0 sites62 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- SLE
- Sponsor
- niversitair Medisch Centrum Utrecht
- Enrollment
- 62
- Status
- Withdrawn
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients full\-filling the ACR criteria for systemic lupus erythematosus
Exclusion Criteria
- •patients with proven other auto\-immune disorders
- •Pregnant women
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Identification of therapeutic target and disease specific marker of atopic dermatitis using proteomic analysis for tissue and bloodDiseases of the skin and subcutaneous tissueKCT0000509Keimyung University31
Recruiting
Not Applicable
Tissue- and blood-based marker profiles for treatment response to combination treatment of surface hyperthermia and hypofractionated radiotherapy for locally recurrent breast carcinoma.C50.8locally recurrent breast cancerC50.9C44.5Overlapping lesion of breastBreast, unspecifiedSkin of trunkDRKS00029221niversitätsklinikum Freiburg40
Recruiting
Not Applicable
Validation of novel biomarkers for treatment response to rush oral immunotherapy for food allergy in childreFood allergyJPRN-UMIN000029742Department of Clinical Research, Mie National Hospital30
Withdrawn
Not Applicable
A search for novel therapeutic targets and biomarkers in patients with Systemic Lupus ErythematosusSLEsystemic lupus erythematosus10003816NL-OMON36575niversitair Medisch Centrum Utrecht75
Active, not recruiting
Not Applicable
A Biomarker Exploration Study of Precision Treatment in Ovarian CancerOvarian CancerBiomarkerNCT06483425Tongji Hospital2,000